{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:28:05Z","timestamp":1793636885193,"version":"4.5.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.gene.2022.146340","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T20:26:40Z","timestamp":1645129600000},"page":"146340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["A hypothesis-driven study to comprehensively investigate the association between genetic polymorphisms in EPHX2 gene and cardiovascular diseases: Findings from the UK Biobank"],"prefix":"10.1016","volume":"822","author":[{"given":"Xiaoming","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mulei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2022.146340_b0005","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1476-4598-13-87","article-title":"A 3'UTR polymorphism modulates mRNA stability of the oncogene and drug target Polo-like Kinase 1","volume":"13","author":"Akdeli","year":"2014","journal-title":"Mol. Cancer"},{"issue":"5903","key":"10.1016\/j.gene.2022.146340_b0010","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1126\/science.1156409","article-title":"Genetic mapping in human disease","volume":"322","author":"Altshuler","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.gene.2022.146340_b0015","doi-asserted-by":"crossref","first-page":"9582430","DOI":"10.1155\/2016\/9582430","article-title":"Macrophages and Their Role in Atherosclerosis: Pathophysiology and Transcriptome Analysis","volume":"2016","author":"Bobryshev","year":"2016","journal-title":"Biomed Res. Int."},{"issue":"2","key":"10.1016\/j.gene.2022.146340_b0020","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3132\/dvdr.2008.021","article-title":"Genetic analysis of the soluble epoxide hydrolase gene, EPHX2, in subclinical cardiovascular disease in the Diabetes Heart Study","volume":"5","author":"Burdon","year":"2008","journal-title":"Diab. Vasc. Dis. Res."},{"key":"10.1016\/j.gene.2022.146340_b0025","article-title":"Genome-wide genetic data on \u223c500,000 UK Biobank participants","author":"Bycroft","year":"2017","journal-title":"bioRxiv"},{"issue":"5","key":"10.1016\/j.gene.2022.146340_b0030","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/1479-7364-4-5-284","article-title":"Functional intronic polymorphisms: Buried treasure awaiting discovery within our genes","volume":"4","author":"Cooper","year":"2010","journal-title":"Hum. Genomics"},{"issue":"3","key":"10.1016\/j.gene.2022.146340_b0035","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s11883-002-0023-5","article-title":"Mechanisms of abdominal aortic aneurysm formation","volume":"4","author":"Daugherty","year":"2002","journal-title":"Curr. Atheroscler Rep."},{"issue":"9","key":"10.1016\/j.gene.2022.146340_b0040","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/bioinformatics\/btq126","article-title":"PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations","volume":"26","author":"Denny","year":"2010","journal-title":"Bioinformatics"},{"issue":"12","key":"10.1016\/j.gene.2022.146340_b0045","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/nbt.2749","article-title":"Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data","volume":"31","author":"Denny","year":"2013","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/j.gene.2022.146340_b0050","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1517\/17460441.2014.881354","article-title":"Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseases","volume":"9","author":"Duflot","year":"2014","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.gene.2022.146340_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1874073100701010001","article-title":"Novel Role of Soluble Epoxide Hydrolase in Regulating Cholesterol in Mammalian Cells","volume":"1","author":"Enayetallah","year":"2007","journal-title":"Open Drug Metab. J."},{"issue":"52","key":"10.1016\/j.gene.2022.146340_b0060","doi-asserted-by":"crossref","first-page":"36592","DOI":"10.1074\/jbc.M806315200","article-title":"Opposite regulation of cholesterol levels by the phosphatase and hydrolase domains of soluble epoxide hydrolase","volume":"283","author":"EnayetAllah","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.gene.2022.146340_b0065","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1182\/blood-2010-11-320788","article-title":"Identification of a specific intronic PEAR1 gene variant associated with greater platelet aggregability and protein expression","volume":"118","author":"Faraday","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.gene.2022.146340_b0070","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/01.CIR.0000109487.46725.02","article-title":"Polymorphism of the soluble epoxide hydrolase is associated with coronary artery calcification in African-American subjects: The Coronary Artery Risk Development in Young Adults (CARDIA) study","volume":"109","author":"Fornage","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.gene.2022.146340_b0075","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1161\/HYPERTENSIONAHA.120.16547","article-title":"Urate, Blood Pressure, and Cardiovascular Disease: Evidence From Mendelian Randomization and Meta-Analysis of Clinical Trials","volume":"77","author":"Gill","year":"2021","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.gene.2022.146340_b0080","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1161\/STROKEAHA.107.502179","article-title":"Genetic variation in soluble epoxide hydrolase (EPHX2) is associated with an increased risk of ischemic stroke in white Europeans","volume":"39","author":"Gschwendtner","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.gene.2022.146340_b0085","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fphar.2019.00036","article-title":"Role of Soluble Epoxide Hydrolase in Metabolism of PUFAs in Psychiatric and Neurological Disorders","volume":"10","author":"Hashimoto","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.gene.2022.146340_b0090","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jacc.2017.12.006","article-title":"Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke","volume":"71","author":"Holmes","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.gene.2022.146340_b0095","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1161\/HYPERTENSIONAHA.110.158667","article-title":"Association of Hypertension Drug Target Genes With Blood Pressure and Hypertension in 86 588 Individuals","volume":"57","author":"Johnson","year":"2011","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.gene.2022.146340_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0176-0","article-title":"Stem cell-secreted 14,15-epoxyeicosatrienoic acid rescues cholesterol homeostasis and autophagic flux in Niemann-Pick-type C disease","volume":"50","author":"Kang","year":"2018","journal-title":"Exp. Mol. Med."},{"issue":"7","key":"10.1016\/j.gene.2022.146340_b0105","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1042\/CS20130479","article-title":"Epoxyeicosatrienoic acid analogue lowers blood pressure through vasodilation and sodium channel inhibition","volume":"127","author":"Khan","year":"2014","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.gene.2022.146340_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100488","article-title":"Mendelian randomization case-control PheWAS in UK Biobank shows evidence of causality for smoking intensity in 28 distinct clinical conditions","volume":"26","author":"King","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"17","key":"10.1016\/j.gene.2022.146340_b0115","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1523\/JNEUROSCI.0056-07.2007","article-title":"Polymorphisms in the human soluble epoxide hydrolase gene EPHX2 linked to neuronal survival after ischemic injury","volume":"27","author":"Koerner","year":"2007","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.gene.2022.146340_b0120","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1093\/hmg\/ddl085","article-title":"Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study","volume":"15","author":"Lee","year":"2006","journal-title":"Hum. Mol. Genet."},{"issue":"10","key":"10.1016\/j.gene.2022.146340_b0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002937","article-title":"Genetically determined serum urate levels and cardiovascular and other diseases in UK Biobank cohort: A phenome-wide mendelian randomization study","volume":"16","author":"Li","year":"2019","journal-title":"PLoS Med."},{"key":"10.1016\/j.gene.2022.146340_b0130","first-page":"1","article-title":"Association of EPHX2 R287Q Polymorphism with Diabetic Nephropathy in Chinese Type 2","volume":"2018","author":"Ma","year":"2018","journal-title":"Diabetic Patients."},{"issue":"3","key":"10.1016\/j.gene.2022.146340_b0135","doi-asserted-by":"crossref","first-page":"F740","DOI":"10.1152\/ajprenal.00098.2009","article-title":"Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension","volume":"297","author":"Manhiani","year":"2009","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"1","key":"10.1016\/j.gene.2022.146340_b0140","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ije\/dyx204","article-title":"Software Application Profile: PHESANT: a tool for performing automated phenome scans in UK Biobank","volume":"47","author":"Millard","year":"2018","journal-title":"Int. J. Epidemiol."},{"issue":"2","key":"10.1016\/j.gene.2022.146340_b0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007951","article-title":"Searching for the causal effects of body mass index in over 300 000 participants in UK Biobank, using Mendelian randomization","volume":"15","author":"Millard","year":"2019","journal-title":"PLoS Genet."},{"issue":"5","key":"10.1016\/j.gene.2022.146340_b0150","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/ng.129","article-title":"Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease","volume":"40","author":"Monti","year":"2008","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.gene.2022.146340_b0155","doi-asserted-by":"crossref","first-page":"H2128","DOI":"10.1152\/ajpheart.00428.2008","article-title":"Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo","volume":"295","author":"Motoki","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"8","key":"10.1016\/j.gene.2022.146340_b0160","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.4103\/ijo.IJO_3062_20","article-title":"Deciphering the association of intronic single nucleotide polymorphisms of crystallin gene family with congenital cataract","volume":"69","author":"Nair","year":"2021","journal-title":"Indian J. Ophthalmol."},{"issue":"5431","key":"10.1016\/j.gene.2022.146340_b0165","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1126\/science.285.5431.1276","article-title":"Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids","volume":"285","author":"Node","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.gene.2022.146340_b0170","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.prostaglandins.2018.07.005","article-title":"Association between the EPHX2 p.Lys55Arg polymorphism and prognosis following an acute coronary syndrome","volume":"138","author":"Oni-Orisan","year":"2018","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"1","key":"10.1016\/j.gene.2022.146340_b0175","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1172\/JCI58128","article-title":"Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice","volume":"122","author":"Panigrahy","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.gene.2022.146340_b0180","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1111\/febs.13634","article-title":"Atherosclerosis and aortic aneurysm - is inflammation a common denominator?","volume":"283","author":"Peshkova","year":"2016","journal-title":"FEBS J."},{"issue":"3","key":"10.1016\/j.gene.2022.146340_b0185","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.mnh.0000165894.90748.72","article-title":"Are small changes in serum creatinine an important risk factor?","volume":"14","author":"Praught","year":"2005","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"2","key":"10.1016\/j.gene.2022.146340_b0190","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1124\/mol.64.2.482","article-title":"Polymorphisms in human soluble epoxide hydrolase","volume":"64","author":"Przybyla-Zawislak","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.gene.2022.146340_b0195","doi-asserted-by":"crossref","unstructured":"Roumeliotis, S., et al., 2021. Association of rs11780592 Polymorphism in the Human Soluble Epoxide Hydrolase Gene (EPHX2) with Oxidized LDL and Mortality in Patients with Diabetic Chronic Kidney Disease 2021, 8817502.","DOI":"10.1155\/2021\/8817502"},{"key":"10.1016\/j.gene.2022.146340_b0200","doi-asserted-by":"crossref","first-page":"15054","DOI":"10.1038\/cddiscovery.2015.54","article-title":"CYP-epoxygenase metabolites of docosahexaenoic acid protect HL-1 cardiac cells against LPS-induced cytotoxicity Through SIRT1","volume":"1","author":"Samokhvalov","year":"2015","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.gene.2022.146340_b0205","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10038-003-0103-6","article-title":"Soluble epoxide hydrolase variant (Glu287Arg) modifies plasma total cholesterol and triglyceride phenotype in familial hypercholesterolemia: intrafamilial association study in an eight-generation hyperlipidemic kindred","volume":"49","author":"Sato","year":"2004","journal-title":"J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.gene.2022.146340_b0210","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1161\/HYPERTENSIONAHA.116.07328","article-title":"A Genetic Response Score for Hydrochlorothiazide Use: Insights From Genomics and Metabolomics Integration","volume":"68","author":"Shahin","year":"2016","journal-title":"Hypertension"},{"issue":"14","key":"10.1016\/j.gene.2022.146340_b0215","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1073\/pnas.1221972110","article-title":"Unique mechanistic insights into the beneficial effects of soluble epoxide hydrolase inhibitors in the prevention of cardiac fibrosis","volume":"110","author":"Sirish","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.gene.2022.146340_b0220","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.abb.2004.05.003","article-title":"Polymorphisms in human soluble epoxide hydrolase: effects on enzyme activity, enzyme stability, and quaternary structure","volume":"427","author":"Srivastava","year":"2004","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.gene.2022.146340_b0225","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.gene.2018.04.038","article-title":"Role of sEH R287Q in LDLR expression, LDL binding to LDLR and LDL internalization in BEL-7402 cells","volume":"667","author":"Tang","year":"2018","journal-title":"Gene"},{"issue":"11","key":"10.1016\/j.gene.2022.146340_b0230","doi-asserted-by":"crossref","first-page":"e1008802","DOI":"10.1371\/journal.pgen.1008802","article-title":"A phenome-wide association study of 26 mendelian genes reveals phenotypic expressivity of common and rare variants within the general population","volume":"16","author":"Tcheandjieu","year":"2020","journal-title":"PLoS Genet."},{"key":"10.1016\/j.gene.2022.146340_b0235","article-title":"Anti-inflammatory effects of epoxyeicosatrienoic acids","volume":"2012","author":"Thomson","year":"2012","journal-title":"Int. J. Vasc. Med."},{"key":"10.1016\/j.gene.2022.146340_b0240","doi-asserted-by":"crossref","DOI":"10.1002\/0471142905.hg0119s68","article-title":"Quality control procedures for genome-wide association studies","author":"Turner","year":"2011","journal-title":"Curr. Protoc. Hum. Genet."},{"issue":"4","key":"10.1016\/j.gene.2022.146340_b0245","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/FJC.0b013e318185fa3c","article-title":"Soluble epoxide hydrolase inhibitors reduce the development of atherosclerosis in apolipoprotein e-knockout mouse model","volume":"52","author":"Ulu","year":"2008","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.gene.2022.146340_b0250","doi-asserted-by":"crossref","DOI":"10.1186\/s12859-018-2135-0","article-title":"A simulation study investigating power estimates in phenome-wide association studies","volume":"19","author":"Verma","year":"2018","journal-title":"BMC Bioinf."},{"issue":"10","key":"10.1016\/j.gene.2022.146340_b0255","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrg2164","article-title":"Splicing in disease: disruption of the splicing code and the decoding machinery","volume":"8","author":"Wang","year":"2007","journal-title":"Nat. Rev. Genet."},{"issue":"3","key":"10.1016\/j.gene.2022.146340_b0260","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s11883-010-0108-5","article-title":"Soluble epoxide hydrolase in atherosclerosis","volume":"12","author":"Wang","year":"2010","journal-title":"Curr. Atheroscler. Rep."},{"issue":"7","key":"10.1016\/j.gene.2022.146340_b0265","doi-asserted-by":"crossref","first-page":"e0175508","DOI":"10.1371\/journal.pone.0175508","article-title":"Evaluating phecodes, clinical classification software, and ICD-9-CM codes for phenome-wide association studies in the electronic health record","volume":"12","author":"Wei","year":"2017","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.gene.2022.146340_b0270","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1016\/j.ijcard.2013.05.010","article-title":"Variations in the human soluble epoxide hydrolase gene and recurrence of atrial fibrillation after catheter ablation","volume":"168","author":"Wutzler","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"8","key":"10.1016\/j.gene.2022.146340_b0275","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/FPC.0b013e3283485eb2","article-title":"Association between polymorphisms of CYP2J2 and EPHX2 genes and risk of coronary artery disease","volume":"21","author":"Xu","year":"2011","journal-title":"Pharmacogenet. Genomics"},{"issue":"9","key":"10.1016\/j.gene.2022.146340_b0280","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1161\/ATVBAHA.109.186064","article-title":"Inhibition of soluble epoxide hydrolase attenuated atherosclerosis, abdominal aortic aneurysm formation, and dyslipidemia","volume":"29","author":"Zhang","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"8","key":"10.1016\/j.gene.2022.146340_b0285","doi-asserted-by":"crossref","DOI":"10.1093\/gigascience\/giy090","article-title":"PhenoSpD: an integrated toolkit for phenotypic correlation estimation and multiple testing correction using GWAS summary statistics","volume":"7","author":"Zheng","year":"2018","journal-title":"Gigascience"},{"issue":"2","key":"10.1016\/j.gene.2022.146340_b0290","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.4238\/2015.April.15.11","article-title":"Relationship between EPHX2 gene polymorphisms and essential hypertension in Uygur, Kazakh, and Han","volume":"14","author":"Zhu","year":"2015","journal-title":"Genet. Mol. Res."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111922001597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111922001597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T16:48:47Z","timestamp":1759855727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111922001597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":58,"alternative-id":["S0378111922001597"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2022.146340","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A hypothesis-driven study to comprehensively investigate the association between genetic polymorphisms in EPHX2 gene and cardiovascular diseases: Findings from the UK Biobank","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2022.146340","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"146340"}}